Selected article for: "amino acid and mass spectrometry"

Author: Davis, C. Todd; Chen, Li-Mei; Pappas, Claudia; Stevens, James; Tumpey, Terrence M.; Gubareva, Larisa V.; Katz, Jacqueline M.; Villanueva, Julie M.; Donis, Ruben O.; Cox, Nancy J.
Title: Use of Highly Pathogenic Avian Influenza A(H5N1) Gain-Of-Function Studies for Molecular-Based Surveillance and Pandemic Preparedness
  • Document date: 2014_12_12
  • ID: uz7vqq3r_13
    Snippet: As coordination of international surveillance activities and global sharing of viruses improve (especially in the wake of the 2009 pandemic and emergence of H7N9 viruses in China), molecularly based surveillance has great potential for rapid risk assessment of samples collected as part of active and passive surveillance systems. Real-time feedback to investigators in the field or authorities making policy decisions related to poultry outbreak con.....
    Document: As coordination of international surveillance activities and global sharing of viruses improve (especially in the wake of the 2009 pandemic and emergence of H7N9 viruses in China), molecularly based surveillance has great potential for rapid risk assessment of samples collected as part of active and passive surveillance systems. Real-time feedback to investigators in the field or authorities making policy decisions related to poultry outbreak containment, clinical intervention, and diagnostic methodology, to cite a few examples, will remain critical in the future. In addition, as building laboratory capacity is prioritized in countries impacted the most by endemic H5N1 virus circulation and the higher incidence of human infection, the ability to screen viruses for amino acid markers or lineage-associated molecular determinants by sequencing, pyrosequencing, mass spectrometry, and real-time reverse transcription (RT)-PCR assays will become the reality for more and more laboratories.

    Search related documents:
    Co phrase search for related documents
    • amino acid and critical remain: 1
    • amino acid and global sharing: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • amino acid and great potential: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • amino acid and high incidence: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • amino acid and human infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • clinical intervention and great potential: 1, 2
    • clinical intervention and high incidence: 1, 2, 3, 4, 5, 6
    • clinical intervention and human infection: 1, 2, 3, 4
    • critical remain and future critical remain: 1
    • critical remain and great potential: 1
    • critical remain and high incidence: 1, 2
    • critical remain and human infection: 1, 2, 3
    • global sharing and human infection: 1
    • great potential and high incidence: 1, 2, 3
    • great potential and human infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • high incidence and human infection: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • high incidence and human infection high incidence: 1